# The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

> **NCT03878706** · — · RECRUITING · sponsor: **University of Athens** · enrollment: 240 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03878706
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-11-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03878706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03878706, "The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03878706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*